Recommendation for inclusion in the Authorisation List and public consultation

ECHA is required to submit to the European Commission recommendations of substances that should be subject to authorisation. To this end, ECHA prioritises the substances from the Candidate List to be included in in the Authorisation List.

The prioritisation is based on the available information on intrinsic properties, uses and volumes of the substances in the scope of authorisation. Companies are reminded that information submitted in the registration dossiers remains the main data source for ECHA and the Member States. Registrants are reminded to keep their registration dossiers and data on uses and volumes up to date.

 

Participate in the public consultation

The public consultation typically runs from June to September each year. The documents described below are available to make comments on during the relevant public consultation. For commenting, the forms provided in the table with the proposed substances (when clicking on "Details" for a specific substance) must be used.

 

Documents relevant for public consultation

The draft recommendation includes the draft entries to be inserted in Annex XIV (available under "Related documents"). In addition to its draft recommendation, ECHA provides several background documents which contain the justification and further details regarding the prioritised substances. These substance-specific documents can be found in the table listing the substances proposed to be recommended to the Authorisation List.

An outline of the general approaches used to develop the draft recommendation, and the results of the prioritisation of the SVHCs on the Candidate List are also available under "Related documents".

 

Making comments

If a substance is successfully identified as an SVHC and included in the Candidate List, then ECHA will consider when it should be recommended for inclusion in the Authorisation List. ECHA regularly assesses the substances from the Candidate List to determine which ones should be included in the Authorisation List as a priority. The prioritisation is primarily based on the information in the registration dossiers on uses and volumes of the substance in the scope of authorisation.

Therefore, registrants are encouraged to update their registration dossiers if they have further or more precise information on uses, releases and exposures. Downstream users of the substance are encouraged to communicate relevant information regarding their uses and conditions of use up the supply chain to ensure that registrants have sufficient information to update their registration dossiers.

Comments on the complexity of the supply chain are particularly welcome, as are comments on the review periods, the transitional arrangements or other information indicating the time needed for preparing authorisation applications. Comments on those uses that you believe should be exempted from the authorisation requirement are also welcome. When proposing such exemptions, the conditions outlined in Article 58(2) of REACH should be taken into account. i.e. specific EU (not only national) legislation is in place ensuring that the risk resulting from the specific use of the substance for human health or the environment is properly controlled and imposes minimum requirements relating to the protection of human health or the environment for the use of the substance.

ECHA would be grateful if interested parties could submit their comments in English (where possible). Comments received after the relevant deadline will not be taken into account.

ECHA will respond to any comments submitted. ECHA takes the comments received into account when updating the draft recommendation. This updated draft recommendation will help the Member State Committee to draft its opinion. Taking the MSC opinion into account, ECHA will finalise its recommendation which is then submitted to the European Commission who makes the final decision on which substances to include in the Authorisation List.

 

Confidentiality

Comments provided are normally considered non-confidential and ECHA will make them available to the public on its website. However, there is an opportunity to attach confidential details. In this case, a justification must be given by the submitting person/party explaining why the information is considered confidential. Such confidential information will only be used by ECHA, including its Committees and the European Commission.

It is your responsibility to ensure that no confidential information is included in the public version of the comments (including the name of your organisation/attachment file names etc.). 

There are currently no ongoing consultations.